Why Progyny Stock Is Soaring Today
Key Points
Progyny's third-quarter results were exceptional.
Sales grew by 9% and were up by 23% on an adjusted basis, accounting for the loss of a major customer last year.
Progyny's best-in-class benefits continue to generate strong retention rates among its clients.
- 10 stocks we like better than Progyny ›
Shares of leading fertility and women's health benefits manager Progyny (NASDAQ: PGNY) are up 18% as of 11 a.m. ET on Friday, according to data provided by S&P Global Market Intelligence.
Progyny reported third-quarter earnings Thursday afternoon and sailed past analysts' expectations, leading to today's soaring stock price.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
The company's all-important "selling season" in Q3 saw sales increase by 9%, while management expects its client count and covered lives to rise by 13% apiece once all new clients go live in 2026.
However, these numbers may be even stronger than they appear, as Progyny lost Amazon as a major customer one year ago. Adjusting for this departure, Progyny's sales really grew by an exceptional 23%.
While losing Amazon was seen as a black eye for Progyny's stock over the last year, I'd argue Amazon seems more focused on cutting costs and trimming its workforce than on offering top-tier benefits like Progyny's. And this quarter's exceptional growth seems to back this notion.
Image source: Getty Images.
Progyny remains best in class
Home to an incredible Net Promoter Score of 82 (one of the best I've ever seen), Progyny continues to gain traction not only in the United States but across the globe.
Maintaining a near-100% client retention rate -- while 30% of its clients grew their benefits in some way with Progyny last year -- the company continues to prove indispensable to its customers and their employees (barring Amazon).
Despite its solid growth, Progyny still only trades at 10 times free cash flow (FCF). However, when its stock-based compensation is taken into account, this ratio rises to 30.
Now armed with a net cash balance of over $300 million, ample FCF generation, and a $200 million stock buyback, Progyny seems to have a bright future.
Should you invest $1,000 in Progyny right now?
Before you buy stock in Progyny, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Progyny wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $591,613!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,152,905!*
Now, it’s worth noting Stock Advisor’s total average return is 1,034% — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of November 3, 2025
Josh Kohn-Lindquist has positions in Progyny. The Motley Fool has positions in and recommends Amazon and Progyny. The Motley Fool has a disclosure policy.
Recommended Articles
